Provenance Wealth Advisors’s Eterna Therapeutics ERNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$27	–	567
2023 Q4	$27	Hold	1	–	–	﹤0.01%	594
2023 Q3	$33	Buy	+1	New	+$33	﹤0.01%	483